Autonomous Synthesis Robot Uses AI to Speed Up Chemical Discovery

Chemists of the University of Amsterdam (UvA) have developed an autonomous chemical synthesis robot with an integrated AI-driven machine learning unit. Dubbed 'RoboChem', the benchtop device can outperform a human chemist in terms of speed and accuracy while also displaying a high level of ingenuity. As the first of its kind, it could significantly accelerate chemical discovery of molecules for pharmaceutical and many other applications. RoboChem's first results were published on 25 January in the journal Science.

RoboChem was developed by the group of Prof. Timothy Noël at the UvA's Van't Hoff Institute for Molecular Sciences. Their paper shows that RoboChem is a precise and reliable chemist that can perform a variety of reactions while producing minimal amounts of waste. Working autonomously around the clock, the system delivers results quickly and tirelessly. Noël: "In a week, we can optimise the synthesis of about ten to twenty molecules. This would take a PhD student several months." The robot not only yields the best reaction conditions, but also provides the settings for scale-up. "This means we can produce quantities that are directly relevant for suppliers to the pharmaceutical industry, for example."

The expertise of the Noël group is in flow chemistry, a novel way of performing chemistry where a system of small, flexible tubes replaces beakers, flasks and other traditional chemistry tools. In RoboChem, a robotic needle carefully collects starting materials and mixes these together in small volumes of just over half a millilitre. These then flow through the tubing system towards the reactor. There, the light from powerful LEDs triggers the molecular conversion by activating a photocatalyst included in the reaction mixture. The flow then continues towards an automated NMR spectrometer that identifies the transformed molecules. These data are fed back in real-time to the computer that controls RoboChem. "This is the brain behind RoboChem," says Noël. "It processes the information using artificial intelligence. We use a machine learning algorithm that autonomously determines which reactions to perform. It always aims for the optimal outcome and constantly refines its understanding of the chemistry."

The group put a lot of effort into substantiating RoboChem's results. All of the molecules now included in the Science paper were isolated and checked manually. Noël says the system has impressed him with its ingenuity: "I have been working on photocatalysis for more than a decade now. Still, RoboChem has shown results that I would not have been able to predict. For instance, it has identified reactions that require only very little light. At times I had to scratch my head to fathom what it had done. You then wonder: would we have done it the same way? In retrospect, you see RoboChem's logic. But I doubt if we would have obtained the same results ourselves. Or not as quickly, at least."

The researchers also used RoboChem to replicate previous research published in four randomly selected papers. They then determined whether Robochem produced the same - or better - results. "In about 80% of the cases, the system produced better yields. For the other 20%, the results were similar," Noël says. "This leaves me with no doubt that an AI-assisted approach will be beneficial to chemical discovery in the broadest possible sense."

According to Noël, the relevance of RoboChem and other 'computerised' chemistry also lies in the generation of high-quality data, which will benefit the future use of AI. "In traditional chemical discovery only a few molecules are thoroughly researched. Results are then extrapolated to seemingly similar molecules. RoboChem produces a complete and comprehensive dataset where all relevant parameters are obtained for each individual molecule. That provides much more insight."

Another feature is that the system also records 'negative' data. In current scientific practice, most published data only reflects successful experiments. "A failed experiment also provides relevant data," says Noël. "But this can only be found in the researchers' handwritten lab notes. These are not published and thus unavailable for AI-powered chemistry. RoboChem will change that, too. I have no doubt that if you want to make breakthroughs in chemistry with AI, you will need these kinds of robots."

Slattery A, Wen Z, Tenblad P, Sanjosé-Orduna J, Pintossi D, den Hartog T, Noël T.
Automated self-optimization, intensification, and scale-up of photocatalysis in flow.
Science. 2024 Jan 26;383(6681):eadj1817. doi: 10.1126/science.adj1817

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...